You are here

Article info

Article menu
Download PDFPDF
Review
Vedolizumab: what is the benefit from increasing the dose frequency?

Authors

  1. Correspondence to Dr Sonia Bouri, West Middlesex University Hospital NHS Trust, London, London, UK; soniabouri{at}nhs.net
View Full Text

Citation

Bouri S, Johnston E
Vedolizumab: what is the benefit from increasing the dose frequency?
Drug and Therapeutics Bulletin 2022;60:183-187.

Publication history

  • First published November 28, 2022.
Online issue publication 
November 30, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.